Lunit accelerates global expansion with latest market approvals and major distribution deal – Reuters

South Korean AI medical company Lunit is strengthening its global footprint following a new international distribution deal and market approval.

Last week it was announced that Lunit INSIGHT CXR and MMG received UK Conformity Assessed marking and CE marking in accordance with the latest European regulations for medical devices.

The company says it has become the first software developer as a medical device developer in the Asia-Pacific region to receive both certifications following recent approvals from Taiwan and Canada.

Also last week, Lunit signed a global distribution deal with California-based healthcare platform Under the agreement, Lunit’s two popular INSIGHT solutions, INSIGHT CXR for chest x-ray image analysis and INSIGHT MMG for mammography analysis, will be delivered through the end-to-end deployment platform, which currently spans five markets: States, Australia , Brazil, India and Singapore.

Lunit INSIGHT solutions are already integrated into some of the major global PACS and imaging devices by global vendors such as GE. Health, Philips and Fujifilm. Lunit INSIGHT CXR and MMG are currently used in clinical practice in approximately 1,000 hospitals and healthcare facilities worldwide.


In recent years, South Korean AI imaging companies such as Lunit have obtained local and international permits and agreements to meet the growing demand from hospitals.

One of the big players, Vuno, recently received approval from the South Korean government for their personal ECG devices. Xativ Pro and Xativ R30. Outside the country, the company also received accreditation from Taiwan for its AI bone age analysis software and from Singapore for its AI fundus analysis software.

Another company AITRICS has received a green light from South Korea for its AI patient monitoring solution, and JLK has received approval from Thailand for its AI brain image analysis solution. Coreline Soft also recently received a 510(k) certification from the US Food and Drug Administration for AVIEW RT ACS, an AI-based auto organ contouring solution.

Meanwhile, Lunit has become one of the preferred AI imaging solution providers for South Korean military hospitals under Armed Forces Medical System Artificial Intelligence Transformation Project. He is ready to provide his technology to 30 medical centers of the Korean army, air force and navy. Internationally, its AI solutions have recently been adopted Cathay Life Insurance in Taiwan, Bumrungrad International Hospital in Thailand, the non-profit Baheya Foundation in Egypt, and most recently SEHA, the largest healthcare network in the United Arab Emirates, and BreastScreen NSW in Australia.

According to Statista, the diagnostic imaging market in South Korea is expected to reach The market volume by 2027 will be $1.02 billion, and the average annual growth will be 6% compared to 2022.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker.